Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
2.
Knee Surg Sports Traumatol Arthrosc ; 28(2): 509-518, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31538227

ABSTRACT

PURPOSE: Quadriceps tendon (QT) autograft ACL reconstruction was hypothesized to possess less anterior knee laxity, pivot shift laxity, and lower failure rates than hamstring tendon (HT) autografts. METHODS: Terms "hamstring tendon autograft" and "ACL reconstruction" or "quadriceps tendon autograft" and "ACL reconstruction" were searched in Embase and PubMed. Inclusion criteria required that studies included patients treated for primary ACL injury with reconstruction using either a QT autograft (Group 1) or a HT autograft (Group 2) and instrumented anterior knee laxity assessment. Extracted information included surgical fixation method, graft type, graft thickness or diameter, single vs. double bundle surgical method, publication year, time between the index knee injury and surgery, % women, initial and final subject number, subject age, follow-up length, side-to-side anterior knee laxity difference, Lysholm Score, Subjective IKDC score, anterior knee laxity side-to-side difference grade, ipsilateral pivot shift laxity grade, and failure rate. The Methodological Index for Nonrandomized Studies was used to evaluate study methodological quality. RESULTS: The QT group (Group 1) had 17 studies and the HT group (Group 2) had 61 studies. Overall, Group 2 had greater pivot shift laxity (OR 1.29, 95% CI 1.05-1.59, p = 0.005). Group 2 suspensory femoral fixation had greater pivot shift laxity (OR 1.26, 95% CI 1.01-1.58, p = 0.02) than Group 1 compression femoral fixation. Group 2 compression femoral fixation also had more anterior knee laxity (OR 1.25, 95% CI 1.03-1.52, p = 0.01) than Group 1 compression femoral fixation and higher failure rates based on initial (OR 1.69, 95% CI 1.18-2.4, p = 0.002) and final (OR 1.89, 95% CI 1.32-2.71, p = 0.0003) subject number. Failure rate for HT compression femoral fixation was greater than suspensory femoral fixation based on initial (OR 2.08, 95% CI 1.52-2.84, p < 0.0001) and final (OR 2.26, 95% CI 1.63-3.16, p < 0.0001) subject number. CONCLUSIONS: Overall, QT autografts had less pivot shift laxity and lower failure rates based on final subject number than HT autografts. Compression QT autograft femoral fixation had lower pivot shift laxity than suspensory HT autograft femoral fixation. Compression QT autograft femoral fixation had less anterior knee laxity and lower failure rates than compression HT autograft femoral fixation. Suspensory HT autograft femoral fixation had lower failure rates than compression HT autograft femoral fixation. Greater knee laxity and failure rates may be related to a combination of HT autograft diameter and configuration (tissue quality and dimensions, strands, bundles, and suturing method) variability and fixation mode. LEVEL OF EVIDENCE: Level IV.


Subject(s)
Anterior Cruciate Ligament Injuries/surgery , Anterior Cruciate Ligament Reconstruction/methods , Hamstring Tendons/transplantation , Joint Instability/diagnosis , Quadriceps Muscle/transplantation , Anterior Cruciate Ligament Reconstruction/adverse effects , Autografts , Graft Survival , Humans , Joint Instability/etiology , Knee Joint/surgery , Physical Examination , Tendons/transplantation , Transplantation, Autologous , Treatment Failure
3.
J Arthroplasty ; 31(12): 2810-2813, 2016 12.
Article in English | MEDLINE | ID: mdl-27325368

ABSTRACT

BACKGROUND: The use of cementless femoral components has become the standard in younger patients due to increased implant survivorship and decreased loosening. However, it remains controversial whether these femoral stems can provide comparable results in elderly patients. Therefore, our purpose was to compare the (1) incidence of revisions; (2) clinical outcomes; (3) incidence of postoperative blood transfusions; and (4) differences in complications between the 2 cohorts. METHODS: Seventy-four consecutive patients (78 hips) aged 80 years or older, who underwent primary total hip arthroplasty using a cementless, tapered, femoral stem were retrospectively compared with a matched cohort of 76 patients (78 hips) who were less than 80 years. Mean age was 83 years (range, 80-91 years) vs 59 years (range, 17-79 years) for the matched group. Minimum follow-up was 2 years. Revision rates, clinical outcomes using the Harris Hip Score, incidences of complications, and postoperative transfusion rates were evaluated. RESULTS: In the octogenarian cohort, the aseptic survivorship was 99%, compared with 95% in the matched group. There were 2 aseptic loosenings (2.6%): 1 femoral implant loosening (1.3%) and 1 acetabular loosening, but only 1 revision was performed, as one of the patients declined revision surgery. In the matched cohort, there were 6 revisions (7.7%). There were no significant differences in revision rates between the 2 cohorts, and no significant differences in final Harris Hip Score scores. The incidence of blood transfusion in the study group was 42% vs 19% in control group (P < .01). CONCLUSION: The use of cementless, tapered, femoral stems yielded excellent results in the octogenarian group, although adequate patient preoperative optimization is necessary given the significantly higher transfusion incidence.


Subject(s)
Arthroplasty, Replacement, Hip/instrumentation , Blood Transfusion/statistics & numerical data , Hip Prosthesis , Postoperative Complications/epidemiology , Reoperation/statistics & numerical data , Acetabulum/surgery , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Arthroplasty, Replacement, Hip/adverse effects , Arthroplasty, Replacement, Hip/mortality , Female , Femur/surgery , Follow-Up Studies , Humans , Kentucky/epidemiology , Male , Middle Aged , Postoperative Complications/etiology , Postoperative Period , Retrospective Studies , Survival Rate , Treatment Outcome , Young Adult
4.
Int J Cardiol ; 110(3): 429-30, 2006 Jun 28.
Article in English | MEDLINE | ID: mdl-16580752

ABSTRACT

We hereby report a case that appeared to have had recurrent clinical heart failure secondary to high-output state due to oversized arteriovenous fistula. Patient started to have dyspnea on exertion approximately 4 months after the creation of the fistula, and subsequently had two episodes of heart failure exacerbation. On both occasions, she had normal left ventricular systolic function as demonstrated by echocardiogram. The shunt was estimated to be as large as 1.9 L/min. B-type natriuretic peptide (BNP) levels were markedly elevated. To our knowledge, this is the first case in which BNP level was reported and used in the diagnosis of high-output heart failure.


Subject(s)
Arteriovenous Fistula/complications , Arteriovenous Fistula/pathology , Heart Failure/complications , Heart Failure/physiopathology , Natriuretic Peptide, Brain/blood , Renal Dialysis , Arteriovenous Fistula/blood , Female , Heart Failure/blood , Humans , Middle Aged , Recurrence
SELECTION OF CITATIONS
SEARCH DETAIL
...